As a proof of concept, here we demonstrate that a synthetic peptide with sequence identical to VHCDR3 of a mouse IgM mAb specific for difucosyl human blood group A substance (MoA) could display a potent immunomodulatory activity thus exerting a therapeutic effect against systemic candidiasis without possessing direct candidacidal properties. Here, CD40LG is linked to candidiasis.